Ballicules.com

Molindone

MOBAN

What it isFirst-generation D2-antagonist antipsychotic for schizophrenia.

Why this oneTends to cause less weight gain than many antipsychotics, but has no unique efficacy advantage.

What limits itExtrapyramidal symptoms, akathisia, hyperprolactinemia, and multiple-daily dosing limit use.

FDA-approved for

FDA label

BOXED WARNING Increased mortality in elderly patients with dementia-related psychosis; not approved for dementia-related psychosis.
FDA dosingPopulationStartTargetMax
Psychotic disorder (antipsychotic)Adult50–75 mg/day225 mg/day (severe)

Titration Increase to 100 mg/day in 3–4 days.

Renal Undefined

Hepatic Undefined

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy Animal studies show no teratogenic potential; third-trimester exposure risks neonatal EPS/withdrawal; use only if benefit justifies risk.

Lactation Undefined

⚠ BOXED WARNING

Cost, est. cash$10–$500/month

Generic entry2015

Classes and tags

Clinical profile

Therapeutic safety burden2 / 4
Overdose danger2 / 4
Weight-gain liability1 / 4
Sedation liability1 / 4
QT / Torsades1 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk2 / 4

Legacy pregnancy categoryC

Defining liabilityMetabolic effects, extrapyramidal symptoms/tardive dyskinesia and agent-specific QT or orthostatic risk.

Mechanism of action: Molindone ballicule

Molindone ballicule: receptor binding, kinetics and half-life diagram

Open Molindone in the interactive console ↗

Memory aids: mascots and interaction avatars

Molindone MOBAN mascot mnemonic cartoon
“Mole Dome Mole ban”
Spooky mascot → antipsychotic
Yardstick → short half-life
Banned mole → not withdrawn from market but intermittently unavailable
Molindone Box: minimal PK interactions avatar
Box: minimal PK interactions

Open Molindone in the interactive console ↗